The impact of HLA sensitization and donor cause of death in heart transplantation

Transplantation

Volumn 70, Issue 1, 2000, Pages 220-222

  Bishay, Ehab S ^a   Cook, Daniel J ^a,b   El Fettouh, Hazem ^a   Starling, Randall C ^b   Young, James B ^b   Smedira, Nicholas G ^a   McCarthy, Patrick M ^a  

^a Allogen Laboratories   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; DEMOGRAPHY; DONOR; FEMALE; HEART TRANSPLANTATION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIZATION;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; HEART TRANSPLANTATION; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; TISSUE DONORS;

EID: 0034661610     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Cecka JM, Terasaki PI. Improvement of kidney transplant regraft results by using trauma death donors. Transplantation 1987; 44 (6): 792.
2. Hurley JP, Cook DJ, McCarthy PM, et al. Flow cytometry cross-matching: a method for monitoring antidonor antibodies in heart transplant recipients. Transplant Proc 1995; 27 (1): 1301.
3. Terasaki PI, Bernoco D, Parks MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA A, B and D antigens. Am J Clin Pathol 1978; 69: 103.
4. Terasaki P, Mickey M, Iwaki Y, et al. Long-term survival of kidney grafts. Transplant Proc 1989; 21 615.
5. McCloskey D, Festenstein H, Banner N, et al. The effect of HLA lymphocytotoxic antibody status and crossmatch result on cardiac transplant survival. Transplant Proc 1989; 21: 804.
6. Opelz G, Reichert B, Mollner H. Preliminary results of the collaborative heart transplant study. In: Thompson ME, ed. Cardiac transplantation. Philadelphia, PA: FA Davis Co; 1990; 91.
7. Lavee J, Kormos RL, Duquesnoy RJ, et al. Influence of panel reactive antibody and lymphocytoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant 1991; 10: 921.
8. Kobashigawa JA, Sabad A, Drinkwater D, et al. Pretransplant panel reactive-antibody screens: are they truly a marker for poor outcome after cardiac transplantation? Circulation 1996; 94 (suppl II): II-294.
9. Corry RJ, Patel NP, West JC, Schanbacher BA. Pretreatment of cadaver donors with cyclophosphamide and methylprednisolone: effect on renal transplant outcome. Transplant Proc 1980; 12: 348.
10. Frisk B, Berglin E, Brynger H. Transfused cadaver kidney donors and graft survival. Transplantation 1983; 35: 352.